RO5429083
Sponsors
Hoffmann-La Roche
Conditions
Myelogenous Leukemia, AcuteNeoplasms
Phase 1
A Study of RO5429083 in Patients With Metastatic and/or Locally Advanced, CD44-Expressing, Malignant Solid Tumors
CompletedNCT01358903
Start: 2011-06-30End: 2014-03-31Updated: 2016-11-02
A Study of RO5429083 Alone or in Combination With Cytarabine in Patients With Acute Myelogenous Leukemia
CompletedNCT01641250
Start: 2012-08-31End: 2015-02-28Updated: 2016-11-02